Skip to main content

True-EBV negative MS is not MS


I have almost completed a paper with a colleague and friend Viqar Chamoun. He was a contemporary of mine when I did my PhD. Chamoun and I worked in the same laboratory and we spent many hours chewing the cud together. Chamoun is a very deep thinker and got me interested in medical philosophy and the application of logic to defining a disease. Chamoun worked on neurosarcoidosis and developed a set of logical steps to show that contemporary diagnostic criteria for neurosarcoidosis were based on tautology. Despite his logical approach we never got his seminal paper published. The plan is to publish it now and in parallel with a paper defining MS as a biological disease and setting-out the principles of how we should incorporate biomarkers into the diagnostic criteria to improve both the sensitivity and specificity of the current criteria.

Viqar Chamoun - thinker extraordinaire
 
Surprise, surprise one of the biomarkers we want to explore is EBV seropositivity. However, to validate a new set of diagnostic criteria to define MS as biological rather than a clinico-radiological construct will require a post-mortem study and will take decades to complete. I am also not sure the wider MS community is ready for us to redefine MS as a biological disease.

I am not surprised by the study below that found paediatric anti-MOG syndrome masquerading as MS. Diagnosing MS is always difficult in children. Please remember even if you fulfil the contemporary definition of having MS at post-mortem about 1 in 20 of you will not have MS and I suspect this will be even higher in children with MS. I have been saying for years that true EBV negative MS is not MS. When I say true EBV-negative MS is that you have to remember that standard diagnostic assays for detecting anti-EBV antibodies are not 100% sensitive. In summary, it is very difficult to find true-EBV negative people with MS.

I have had a recurring dream of finding and studying a cohort of true EBV-negative MS patients, but there are too few such patients to study. When we found 32 patients, in our large international CIS study of over 1000 patients, who were seronegative for EBV we shipped their samples to Jaap Middledorp’s EBV laboratory in Amsterdam for more detailed testing. When the results came back 31 of the 32 were positive and one was equivocal with Jaap’s more sensitive assays.

So yes I think ‘true-EBV negative MS is not MS’ and that applies to paediatric MS as well. The data below is very important and strongly supports EBV as being the cause of MS and is screaming out for us to start our EBV-vaccine MS prevention study ASAP. Do you agree?

Bardia Nourbakhsh et al. MS is rare in EBV-seronegative children with CNS inflammatory demyelination. Ann Neurol. 2021 Mar 11. doi: 10.1002/ana.26062. Online ahead of print.

Although Epstein-Barr virus (EBV) is hypothesized to be a prerequisite for multiple sclerosis (MS), up to 15% of children with a diagnosis of MS were reported to be EBV-seronegative. When re-evaluating 25 EBV-seronegative children out of 189 pediatric patients with a diagnosis of clinically isolated syndrome/MS, we found anti-myelin oligodendrocyte glycoprotein (MOG) antibody in 11/25 (44%) EBV-seronegative, but only 9/164 (5.5%, p < 0.001) EBV-seropositive patients. After critical review, MS remained a plausible diagnosis in only four of 14 EBV-seronegative/MOG antibody-negative patients. In children with an MS-like presentation, EBV seronegativity should alert clinicians to consider diagnoses other than MS, especially MOG-antibody disease. This article is protected by copyright. All rights reserved.

CoI: multiple

Twitter: @gavinGiovannoni                         Medium: @gavin_24211

Comments

  1. Prof G what antibody tests do you recommend for detecting EBV?

    ReplyDelete
  2. The standard screen is anti-EBNA-1 and anti-VCA (viral capsid antigen). If you are unsure you can do anti-EA (early antigen), but that is usually as part of IM.

    ReplyDelete
  3. Could you please share your opinion on ATA188 latest figures?

    ReplyDelete
    Replies
    1. Have yet to see the final data-cut. The treatment needs to go into a proper double-blind randomised controlled study to convince me. Nothing I have seen so far would argue against the next phase.

      Delete

Post a Comment

Popular posts from this blog

Corpulence and poverty

Since stating my intention to join the  #BackTo21  campaign to get my BMI back to what it was when I was 21 years of age, I have had several emails and direct messages on social media questioning the wisdom of my intention.  Photo by NeONBRAND on Unsplash It is clear that despite BMI being a relatively poor metric of health there is overwhelming evidence that at a population level it predicts poor health outcomes. Importantly there is new data that indicates the target BMI for the prevention of type 2 diabetes and the metabolic syndrome depends on your ethnicity. For people of South Asian origin, there is a call to reset the BMI cutoff to 23.9, which for most people is within the normal range. At the same time, there is a call to classify obesity as an important social determinant of health. Arnaud Chiolero argues below for using BMI as a socioeconomic indicator. Do you agree? Isn’t it quite amazing that in a previous era corpulence was a sign of affluence, whereas in th...

Moved to substack

Dear Reader We have moved the preventive neurology unit blog to a new platform called substack . Google is discontinuing its Feedburner and has not added many new features to blogger for some time, which is why we have decided to move the site.  https://preventiveneurology.substack.com/  Thanks Gavin Giovannoni

To be teetotal or not

In summary, any form and any amount of alcohol consumption is unhealthy for the brain. Photo by Hush Naidoo on Unsplash He was only 64 when his daughter noticed that his forgetfulness had started to impact on his ability to function independently. Her father had forgotten to pay the gas and electricity bill and social services had contacted her as next of kin to find out why. It was clear that years of excessive alcohol was having an impact on his memory. The scenario above is one that is played out across society thousands of times if not hundreds of thousands of times. This is why the study below from the UK biobank is so worrying; when it comes to brain volume, a crude measure of the brain's neuronal and cognitive reserve, there is no safe alcohol consumption limit. Importantly, comorbidities such as high blood pressure and obesity interacted with alcohol consumption to reduce brain health. Not surprisingly binging on alcohol made things worse and this was over and above the vo...